Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-07-16 | 2020-07-23 | 120500 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-07-16 | 2020-09-24 | 120503 |
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-07-23 | 2020-08-17 | 120875 |
TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120878 |
TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120881 |
TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2020-07-23 | 2020-09-17 | 120884 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-07-23 | 2020-08-21 | 120887 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120890 |
TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120893 |
TEVA-TECNAL | 50MG 40MG 330MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120896 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120899 |
TEVA-CINACALCET | 30MG | TABLET | Resolved | 2020-07-23 | 2021-03-18 | 120902 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120905 |
TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120908 |
RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2020-07-23 | 2020-10-15 | 120911 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120914 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120917 |
TEVA-PROPOFOL | 10MG | EMULSION | Actual shortage | 2020-07-30 | 2020-07-30 | 121494 |
TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Actual shortage | 2020-07-30 | 2021-10-14 | 121497 |
TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-07-30 | 2020-08-17 | 121500 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |